Fundraising FoxGenten Therapeutics
San Francisco, US · Founded 2016 · Delaware corporation
Find your way into Genten Therapeutics
Sign up to see every warm intro you have to Genten Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genten Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
CJ
Craig JohnsonBoard director
DM
David MauneyBoard director
Reported raises · per SEC filings
Form D private placements$12M disclosed across 1 round · 2016
▶$12MraisedOct 2016 · 3 investors · BiotechnologyRule 506(b)
▶$12MraisedOct 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig JohnsonExecutive Officer, Director
- David MauneyExecutive Officer, Director
- Offering amount
- $22M
- Amount sold
- $12M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Genten Therapeutics raised?
- Genten Therapeutics has disclosed $12M raised across 1 round.
- Where is Genten Therapeutics headquartered?
- Genten Therapeutics is headquartered in San Francisco, US.